Clinical Trial Update: Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

View source ↗

Summary

Completed clinical trial evaluating eslicarbazepine acetate as add-on therapy to a single baseline antiepileptic drug for epilepsy (ESLADOBA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Status: COMPLETED